Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.395 +0.145 (+3.41%)
Streaming Delayed Price Updated: 12:31 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 183,232
Open 4.260
Bid (Size) 4.390 (1)
Ask (Size) 4.400 (5)
Prev. Close 4.250
Today's Range 4.260 - 4.435
52wk Range 4.140 - 9.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... 
Via Benzinga
Exposures Glyphosate

Performance

YTD
-29.74%
-29.74%
1 Month
-26.01%
-26.01%
3 Month
-27.59%
-27.59%
6 Month
-20.52%
-20.52%
1 Year
-14.33%
-14.33%

More News

Read More
Exscientia Earnings Preview
Via Benzinga
Six Of Seven AI Stock Categories Increased This Week
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Exscientia Business and Financial Update for the Full Year 2023
From Exscientia plc
Via Business Wire
Earnings Scheduled For March 21, 2024
Via Benzinga
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
From Exscientia plc
Via Business Wire
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Via InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Via Talk Markets
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia plc
Via Business Wire
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
From Exscientia plc
Via Business Wire
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
Via InvestorPlace
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
From Exscientia
Via Business Wire
Top Picks 2024: Exscientia Plc
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI-Focused Drug Discovery Stocks Index Up 26% In December
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.